Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

CMAJ. 2020 Oct 5;192(40):E1156-E1161. doi: 10.1503/cmaj.201240. Epub 2020 Aug 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticoagulants / therapeutic use
  • Betacoronavirus*
  • Blood Coagulation Disorders / etiology
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / therapy
  • Critical Illness
  • Humans
  • Monitoring, Physiologic
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / therapy
  • SARS-CoV-2
  • Thrombosis / etiology*
  • Thrombosis / prevention & control
  • Venous Thromboembolism / etiology*
  • Venous Thromboembolism / prevention & control

Substances

  • Anticoagulants